title: Charles Bonnet syndrome and opioids.
authors.forename: M A
authors.initials: MA
authors.lastname: Benítez del Rosario
authors.forename: F
authors.initials: F
authors.lastname: Montón
authors.forename: A
authors.initials: A
authors.lastname: Salinas
authors.forename: J J
authors.initials: JJ
authors.lastname: Martín
authors.forename: M
authors.initials: M
authors.lastname: Feria
mesh_terms: D000368:Aged; D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001766:Blindness / Q000150:complications*; D003937:Diagnosis, Differential; D017809:Fatal Outcome; D006212:Hallucinations / Q000139:chemically induced* / Q000175:diagnosis / Q000517:prevention & control; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010146:Pain / Q000188:drug therapy / Q000209:etiology; D011471:Prostatic Neoplasms / Q000150:complications; D012307:Risk Factors; D013577:Syndrome
chemical_list: D000701:Analgesics, Opioid; D014150:Antipsychotic Agents; D006220:Haloperidol